These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 5524749)
21. Topical tacrolimus in the treatment of localized scleroderma. Mancuso G; Berdondini RM Eur J Dermatol; 2003; 13(6):590-2. PubMed ID: 14721783 [TBL] [Abstract][Full Text] [Related]
22. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol]. Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343 [No Abstract] [Full Text] [Related]
23. [Use of dimethyl sulfoxide (DMSO) for treating flexion contractures in rheumatoid arthritis patients]. Murav'ev IuV; Aliab'eva AP Ter Arkh; 1984; 56(9):128-9. PubMed ID: 6515539 [No Abstract] [Full Text] [Related]
24. [Treatment of amyloidosis with dimethyl sulfoxide (DMSO)]. Morassi P; Massa F; Mesesnel E; Magris D; D'Agnolo B Minerva Med; 1989 Jan; 80(1):65-70. PubMed ID: 2915815 [TBL] [Abstract][Full Text] [Related]
25. Clinical images: Progressive calcifications and draining lesions following staphylococcal infection in a patient with limited scleroderma. Pando J; Nashel DJ Arthritis Rheum; 1998 Feb; 41(2):373. PubMed ID: 9485097 [No Abstract] [Full Text] [Related]
26. Stimulating circulation to end stasis in scleroderma. Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844 [No Abstract] [Full Text] [Related]
27. Use of dimethyl sulfoxide (DMSO) in Peyronie's disease; a preliminary report. Scheinman LJ; Miller EV Pac Med Surg; 1967; 75(1):61-2. PubMed ID: 6044596 [No Abstract] [Full Text] [Related]
29. Treatment of localised scleroderma by UVA1 phototherapy. Kerscher M; Dirschka T; Volkenandt M Lancet; 1995 Oct; 346(8983):1166. PubMed ID: 7475636 [No Abstract] [Full Text] [Related]
30. Clinical experiences with dimethyl sulfoxide (DMSO) in human subjects. Approval must be withheld until safety in extended use is established. Savastano AA R I Med J (1976); 1984 Mar; 67(3):119-21. PubMed ID: 6587509 [No Abstract] [Full Text] [Related]
31. Lack of ocular changes with dimethyl sulfoxide therapy of scleroderma. Shirley HH; Lundergan MK; Williams HJ; Spruance SL Pharmacotherapy; 1989; 9(3):165-8. PubMed ID: 2755866 [TBL] [Abstract][Full Text] [Related]
32. [Systemic sclerosis (scleroderma) without scleroderma]. Nadashkevych ON Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041 [TBL] [Abstract][Full Text] [Related]
33. The discrepancy in hardness between clinical and histopathological findings in localized scleroderma treated with PUVA. Yamaguchi K; Takeuchi I; Yoshii N; Gushi A; Kanekura T; Kanzaki T J Dermatol; 1998 Aug; 25(8):544-6. PubMed ID: 9769602 [TBL] [Abstract][Full Text] [Related]
35. [Pulmonary changes in lupus erythematosus and scleroderma]. Bessler W; Meyer C Radiol Clin Biol; 1970; 39(3):230-9. PubMed ID: 5475001 [No Abstract] [Full Text] [Related]
36. [Centrally caused or general analgetic effect of locally administered dimethyl sulfoxide (DMSO)]. von der Hardt H; Röper HJ; Sudhof H Med Welt; 1969 Mar; 11():606-9. PubMed ID: 5305762 [No Abstract] [Full Text] [Related]
37. [Short term examination of additional pulpitis agents (combination preparations with dimethyl sulfoxide (DMSO). (2)]. Triadan H; Thieme E SSO Schweiz Monatsschr Zahnheilkd; 1969 May; 79(5):645-50. PubMed ID: 4890090 [No Abstract] [Full Text] [Related]
38. Dimethyl sulfoxide (DMSO): laboratory and clinical evaluation. Jacob SW; Herschler RJ; Rosenbaum EE J Am Vet Med Assoc; 1965 Dec; 147(12):1350-9. PubMed ID: 5894316 [No Abstract] [Full Text] [Related]
39. [Treatment results with dimethyl sulfoxide in circumscribed scleroderma]. Gärtner R; Flegel H Dermatol Wochenschr; 1968 Oct; 154(43):1015-22. PubMed ID: 5733089 [No Abstract] [Full Text] [Related]